Drug profile · INN
gentian violet
GVS
gentian violet (GVS) is a dna inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gentian violet
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gentian violet (GVS) is a dna inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
INN gentian violet
Brand GVS
Mechanism DNA inhibitor
Target DNA
Route VAGINAL
Formulation TAMPON
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is gentian violet?
gentian violet (GVS) is a dna inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for gentian violet?
GVS is a marketed brand name for gentian violet. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gentian violet?
gentian violet has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.